Last year, the Department of Health commissioned Deloitte Access Economics to undertake a review of the National Bowel Cancer Screening Program. The review will explore aspects related to the implementation and delivery of the program, as well as the outcomes achieved for consumers, providers, and the broader health care system.
The review is seeking your input via a short survey.
For those who were unable to participate due to the constrained time frames, the closing date for the survey has been extended to Friday 5 February 2021.
The survey will take approximately 10-20 minutes to complete. Deloitte will not be collecting any personal information. Responses will not be identifiable, as the data will be reported to the Department of Health at an aggregate thematic level.
If you have any questions or comments about the survey, please contact the Deloitte team at [email protected].